Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KKOYY | GMED |
|---|---|---|
| Price | $12.91 | $76.57 |
| Change today | ▲ 0.73% | ▲ 1.28% |
| Market cap | $10.28B | $10.28B |
| Return, 3 months | +18.7% | -2.9% |
| Return, year to date | +17.6% | -12.3% |
| Return, 1 year | +24.5% | +27.3% |
| P/E (TTM) | 21.2 | 19.6 |
| P/B | 3.5 | 2.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 4.04% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 52 | 50 |
| 30-day volatility | 17.4% | 23.8% |
| Max drawdown, 1 year | -15.5% | -24.0% |
| Trend read | Strong uptrend | Mixed |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
